Evidence map›Paper›PMID 42256230›Full record

ArticleFrontiers in cellular and infection microbiology2026

Salvianolic acid B synergizes with azoles against

Yisheng Chen, Yuping Zhang, Loukaiyi Lu, Qiang Wang, Jing Gao, Chunmei Ying

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yisheng Chen *Obstetrics & Gynecology Hospital of Fudan University, Shanghai Key Lab of Reproduction and Development, Shanghai Key Lab of Female Reproductive Endocrine Related Diseases, Shanghai, China.
Yuping Zhang *Joint Laboratory for Biomedical Research and Pharmaceutical Innovation, The Unit of Pathogenic Fungal Infection & Host Immunity, Shanghai Institute of Materia Medica, Shanghai Institute of Immunity and Infection, Chinese Academy of Sciences, Shanghai, China.
Loukaiyi LuObstetrics & Gynecology Hospital of Fudan University, Shanghai Key Lab of Reproduction and Development, Shanghai Key Lab of Female Reproductive Endocrine Related Diseases, Shanghai, China.
Qiang WangObstetrics & Gynecology Hospital of Fudan University, Shanghai Key Lab of Reproduction and Development, Shanghai Key Lab of Female Reproductive Endocrine Related Diseases, Shanghai, China.
Jing GaoObstetrics & Gynecology Hospital of Fudan University, Shanghai Key Lab of Reproduction and Development, Shanghai Key Lab of Female Reproductive Endocrine Related Diseases, Shanghai, China.
Chunmei YingObstetrics & Gynecology Hospital of Fudan University, Shanghai Key Lab of Reproduction and Development, Shanghai Key Lab of Female Reproductive Endocrine Related Diseases, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The rising prevalence of antifungal resistance poses a significant threat to global health, with Objectives: This study aimed to evaluate the antifungal efficacy of SAB alone and in combination with azoles against Methods: The antifungal efficacy of SAB alone and in combination with fluconazole (FLC), itraconazole (ITC), and voriconazole (VRC) was assessed against Results: SAB exhibited marked synergistic activity with azoles against azole-resistant Conclusion: SAB synergistically enhances azoles activity against drug-resistant

Indexed as

Antifungal AgentsAzolesBenzofuransCandida glabrataCandidiasis, VulvovaginalDrug SynergismAnimalsDepsidesDisease Models, AnimalDrug Resistance, FungalFemaleHumansItraconazoleMicrobial Sensitivity TestsAntifungal AgentsAzolesBenzofuransDepsidesItraconazolesalvianolic acid Bantifungal activityazole synergistCandida glabratasalvianolic acid Bvulvovaginal candidiasis

Identifiers

PMID42256230
PMCPMC13236911

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.